University College London
Cancer Biomedicine
Typical offer rate
67–77%
moderate entry
Typical entry
AAA
Grad employment
98%
15 months after
In professional roles
97%
Median grad salary
£37,500
15 months after
UCL's cancer biomedicine programme studies the molecular and cellular biology of cancer, encompassing tumour biology, immunology and the pharmacological basis of cancer treatment. It is a rigorous science degree for students aiming at research or clinical science careers in oncology. The offer rate is moderate; offers are made around AAA at A-level.
How hard is it to get in?
The typical applicant to Cancer Biomedicine at University College London has a 67–77% chance of an offer, moderate by UK standards. Most offers are made around AAA at A-level. That baseline is course-typical. Your own chance depends on your grades, subjects and the rest of your profile.
See your personalised chances
Unimetrica estimates your individual offer likelihood for this course from your predicted grades and profile. It shows how it fits into your best five UCAS choices.
Estimate my chancesEntry requirements
- Typical A-level grades: AAA
- UCAS tariff: 144–144 points
About University College London
University College London was the first university in England to admit students regardless of religion and among the first to admit women, on its Bloomsbury campus in central London.
Full details and how to apply are on the university's official course page: University College London · Cancer Biomedicine
Offer rate and graduate-outcome figures are course-typical baselines derived from UK admissions and HESA data; they are estimates, not guarantees. Your personalised offer likelihood is calculated in the Unimetrica app.